The Indian pharmaceutical industry is seeking relief from planned US tariffs through bilateral talks. Top Indian drugmakers are relying on diplomatic efforts to resolve the issue, which could impact their exports to the US market.
Indian pharmaceutical companies are exploring options to mitigate the effects of the tariffs, which could disrupt their business operations and impact their revenue. The outcome of the talks will be crucial for the Indian pharmaceutical industry, which is a significant player in the global market.